Skip to main content
. 2016 Oct 19;2016:9836860. doi: 10.1155/2016/9836860

Figure 5.

Figure 5

Schematic diagram for the possible mechanisms of the cardioprotection of resveratrol in diabetic cardiomyopathy. By binding to RAGE or TLRs, HMGB 1 stimulates ROS production and activation of NF-κB, which triggers inflammation and fibrosis in diabetic hearts. Increased ROS production and inflammation may be responsible for upregulated HMGB 1 with a positive feedback. Treatment with resveratrol attenuates genesis of ROS and HMGB 1 to prevent cardiac dysfunction in diabetes.